BR112014024129A2 - Método e kit para a classificação e prognóstico das feridas - Google Patents

Método e kit para a classificação e prognóstico das feridas

Info

Publication number
BR112014024129A2
BR112014024129A2 BR112014024129A BR112014024129A BR112014024129A2 BR 112014024129 A2 BR112014024129 A2 BR 112014024129A2 BR 112014024129 A BR112014024129 A BR 112014024129A BR 112014024129 A BR112014024129 A BR 112014024129A BR 112014024129 A2 BR112014024129 A2 BR 112014024129A2
Authority
BR
Brazil
Prior art keywords
wounds
prognosis
kit
classification
wound
Prior art date
Application number
BR112014024129A
Other languages
English (en)
Inventor
Dugast Darzacq Claire
Darzacq Xavier
Noizet Maïté
Lagoutte Emilie
Roest Crollius Hugues
Gratigny Marlène
Bouschbacher Merielle
Original Assignee
Centre Nat Rech Scient
Vivatech
Univ Paris Diderot Paris 7
Ecole Normale Superieure
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Vivatech, Univ Paris Diderot Paris 7, Ecole Normale Superieure filed Critical Centre Nat Rech Scient
Publication of BR112014024129A2 publication Critical patent/BR112014024129A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

MÉTODO E KIT PARA A CLASSIFICAÇÃO E PROGNÓSTICO DAS FERIDAS. A presente invenção se refere a um método e um kit para a classificação e prognóstico de feridas em mamíferos, em especial, em humanos. O método define uma assinatura molecular que permite caracterizar uma cicatrização de ferida patológica, tal como uma ferida crônica ou ferida sem cicatrização.
BR112014024129A 2012-03-30 2013-03-29 Método e kit para a classificação e prognóstico das feridas BR112014024129A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2012/000906 WO2013144672A1 (en) 2012-03-30 2012-03-30 Method and kit for the classification and prognosis of wounds
PCT/EP2013/056830 WO2013144348A1 (en) 2012-03-30 2013-03-29 Method and kit for the classification and prognosis of wounds

Publications (1)

Publication Number Publication Date
BR112014024129A2 true BR112014024129A2 (pt) 2017-08-22

Family

ID=48040243

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014024129A BR112014024129A2 (pt) 2012-03-30 2013-03-29 Método e kit para a classificação e prognóstico das feridas

Country Status (7)

Country Link
US (2) US20150087527A1 (pt)
EP (4) EP3421614A1 (pt)
JP (2) JP6211052B2 (pt)
CN (1) CN104540963B (pt)
BR (1) BR112014024129A2 (pt)
CA (1) CA2868606A1 (pt)
WO (3) WO2013144672A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2961374A1 (en) * 2014-09-16 2016-03-24 Oncomed Pharmaceuticals, Inc. Treatment of fibrotic diseases
KR101589285B1 (ko) * 2014-09-23 2016-01-27 한국생명공학연구원 심혈관 질환 마커 파랄레민 및 이를 이용한 심혈관 질환 진단 방법
CN105853421B (zh) * 2015-01-22 2019-02-05 北京大学 FoxO1选择性抑制剂AS1842856的新用途
WO2016205259A1 (en) * 2015-06-14 2016-12-22 Hoke Glenn Dale Methods of diagnosing and treating wounds
CN107817342B (zh) * 2016-09-14 2019-06-25 北京大学 软骨寡聚基质蛋白作为标志物在诊断腹主动脉瘤或动脉夹层中的应用
CN106512102B (zh) * 2016-11-03 2019-06-18 杭州枫霖科技有限公司 一种促进间充质干细胞软骨组织分化的方法
WO2018227299A1 (en) 2017-06-14 2018-12-20 Mcmaster University Biomarkers for wound healing
TWI774059B (zh) * 2020-09-14 2022-08-11 國立陽明大學 Ｃｘｃｌ５中和抗體用於製備預防或治療周邊動脈阻塞疾病的藥物的用途
US20220080044A1 (en) * 2020-09-14 2022-03-17 National Yang-Ming University Method for preventing or treating peripheral arterial occlusive disease
RU2761893C1 (ru) * 2021-01-25 2021-12-13 Федеральное государственное бюджетное образовательное учреждение высшего образования Иркутский государственный медицинский университет Министерства здравоохранения Российской Федерации Способ прогнозирования результата лазерного лечения гипертрофического рубца у женщин
EP4382115A1 (en) * 2021-08-03 2024-06-12 Chung Ang University Industry Academic Cooperation Foundation Composition for preventing or treating fibrotic diseases, comprising hapln1
JPWO2023042309A1 (pt) 2021-09-15 2023-03-23

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002016599A2 (en) * 2000-08-25 2002-02-28 Curagen Corporation Proteins and nucleic acids encoding same
US8034553B2 (en) * 2004-06-24 2011-10-11 Kimberly-Clark Worldwide, Inc. Biomarkers for wound healing
WO2006042197A2 (en) * 2004-10-11 2006-04-20 The Board Of Trustees Of The Leland Standford Junior University Use of del-1 in hair, bone and cartilage regeneration
US20090220488A1 (en) * 2005-08-31 2009-09-03 Humphrey Gardner Evaluating and treating scleroderma
GB0617116D0 (en) * 2006-08-31 2006-10-11 Renovo Ltd Method of diagnosis
WO2008110356A2 (en) * 2007-03-12 2008-09-18 Robert Frost Protein pi 16 secreted from the heart and uses thereof
EP2155234A1 (en) * 2007-04-10 2010-02-24 The Board of Regents,The University of Texas System Combination therapy for chronic dermal ulcers
EP2235541A2 (en) * 2007-12-13 2010-10-06 3M Innovative Properties Company Methods of analyzing wound samples
WO2010042903A1 (en) * 2008-10-09 2010-04-15 Alfagene Bioscience, Inc Use and identification of biomarkers for gastrointestinal diseases
WO2010045463A2 (en) * 2008-10-15 2010-04-22 Government Of The United States As Represented By The Secretary Of The Army Clinical decision model
US9107942B2 (en) * 2008-10-31 2015-08-18 University Of Rochester Methods of diagnosing and treating fibrosis
US20100204058A1 (en) * 2009-01-28 2010-08-12 Howard Yuan-Hao Chang Profiling for Determination of Response to Treatment for Inflammatory Disease
US9149509B2 (en) * 2009-03-26 2015-10-06 Henry Ford Health System Methods for improving neurological outcome after neural injury and neurodegenerative disease
WO2011006214A1 (en) * 2009-07-16 2011-01-20 Peter Maccallum Cancer Institute Method of detecting radiation exposure and adverse toxicity thereto
GB0916124D0 (en) * 2009-09-15 2009-10-28 Univ Cardiff Method and kit for the classification and prognosis of wounds

Also Published As

Publication number Publication date
EP2831269A1 (en) 2015-02-04
CA2868606A1 (en) 2013-10-03
CN104540963B (zh) 2017-07-25
JP2017195878A (ja) 2017-11-02
EP3421615A1 (en) 2019-01-02
JP2015513898A (ja) 2015-05-18
US20150087527A1 (en) 2015-03-26
WO2013144349A1 (en) 2013-10-03
US20150126447A1 (en) 2015-05-07
EP2831267A1 (en) 2015-02-04
JP6211052B2 (ja) 2017-10-11
WO2013144672A1 (en) 2013-10-03
WO2013144348A1 (en) 2013-10-03
CN104540963A (zh) 2015-04-22
EP3421614A1 (en) 2019-01-02

Similar Documents

Publication Publication Date Title
BR112014024129A2 (pt) Método e kit para a classificação e prognóstico das feridas
UA116196C2 (uk) Синтетичний міметик апеліну для лікування серцевої недостатності
TR201811764T4 (tr) Kinaz inhibitörleri olarak aminoheteroaril benzamidleri.
BR112016017690A2 (pt) Tratamentos para acne resistente
BR112015011933A2 (pt) composições bacterianas sinérgicas e métodos de produção e uso das mesmas
UY4235Q (es) Configuración aplicada en zapato
MX2015012401A (es) Composiciones y metodos de alterar niveles de colesterol.
BR112013029787A2 (pt) biomarcadores para câncer de pulmão
EP3035908A4 (en) Topical skin compositions for treating wrinkles
MX2015015593A (es) Placa de osteosintesis y sistema para osteosintesis.
BR112014029231A2 (pt) método para o fracionamento da lignina
BR112014031806A2 (pt) método para tratamento de câncer positivo para gd2
CL2016000326A1 (es) Composiciones y método para tratar condiciones asociadas con el complemento
CL2015002146A1 (es) Composiciones y procedimientos para tratar heridas superficiales
BR112013024211A2 (pt) tratamento de tumores sólidos
TR201903565T4 (tr) Yara iyileşmesi için yöntemler ve bileşimler.
DE112014005607A5 (de) Antriebssystem sowie damit ausgerüstete Profilieranlage
BR112015023782A2 (pt) conjunto de polias
BR112015022231A2 (pt) comosição fungicida natural
UY33923A (es) Combinación antitumoral que comprende cabazitaxel y cisplatino
BR112013029439A2 (pt) válvula de alívio
BR112016014099A2 (pt) método de tratamento de feridas
BR112014018709A8 (pt) Composições e efetores de beta-arrestina e métodos de uso dos mesmos
MX370176B (es) Método para el tratamiento y/o prevención contra encefalopatia traumática cronica grado i.
WO2015066439A8 (en) Methods of treating hematological malignancies

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2560 DE 2020-01-28